Concepedia

Publication | Open Access

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

245

Citations

36

References

2022

Year

Abstract

Efficacy and Mechanism Evaluation Programme (Medical Research Council and National Institute for Health Research, UK).

References

YearCitations

Page 1